These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 475840)

  • 1. Serotonergic activity of a novel tetrahydro-beta-carboline.
    Davis PA; Baird-Lambert J; Taylor KM; Maclaren JA
    Biochem Pharmacol; 1979 Jun; 28(11):1803-6. PubMed ID: 475840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the reuptake of serotonin by tryptoline.
    Rommelspacher H; Bade P; Coper H; Kossmehl G
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):93-5. PubMed ID: 934360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.
    Buckholtz NS
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(3):215-21. PubMed ID: 6164934
    [No Abstract]   [Full Text] [Related]  

  • 6. Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.
    Langer SZ; Raisman R; Tahraoui L; Scatton B; Niddam R; Lee CR; Claustre Y
    Eur J Pharmacol; 1984 Feb; 98(1):153-4. PubMed ID: 6325207
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline: a specific monoamine oxidase-A inhibitor in CF-1 mouse brain.
    Sparks DL; Buckholtz NS
    Neurosci Lett; 1980 Oct; 20(1):73-8. PubMed ID: 7052551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by beta-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships.
    Buckholtz NS; Boggan WO
    Life Sci; 1977 Jun; 20(12):2093-9. PubMed ID: 18641
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.
    Glover V; Liebowitz J; Armando I; Sandler M
    J Neural Transm; 1982; 54(3-4):209-18. PubMed ID: 7130973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
    Herraiz T; Chaparro C
    J Chromatogr A; 2006 Jul; 1120(1-2):237-43. PubMed ID: 16386263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Methoxyl-1,2,3,4-tetrahydro-beta-carboline effects on retinal serotonin.
    Thomas TN; Buckholtz NS; Zemp JW
    Life Sci; 1979 Oct; 25(16):1435-41. PubMed ID: 522611
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB; Oppenheim B
    Neuroscience; 1981; 6(4):801-10. PubMed ID: 7242917
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetrahydro-beta-carbolines: specific inhibitors of type A monoamine oxidase in rat brain.
    Meller E; Friedman E; Schweitzer JW; Friedhoff AJ
    J Neurochem; 1977 May; 28(5):995-1000. PubMed ID: 864473
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of beta-carbolines of plasma corticosterone in mice.
    Meyer JS; Buckholtz NS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):205-13. PubMed ID: 1085012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline produces a retention deficit for one-trial passive avoidance in mice.
    Buckholtz
    Behav Biol; 1975 May; 14(01):95-101. PubMed ID: 1137537
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism.
    Buckholtz NS
    Prog Clin Biol Res; 1982; 90():183-90. PubMed ID: 7111318
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical characteristics of a potential antidepressant, 2-(7-indenyloxymethyl)morpholine hydrochloride (YM-08054-1).
    Harada M; Maeno H
    Biochem Pharmacol; 1979 Sep; 28(17):2645-51. PubMed ID: 518676
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurobiology of tetrahydro-beta-carbolines.
    Buckholtz NS
    Life Sci; 1980 Sep; 27(11):893-903. PubMed ID: 6107810
    [No Abstract]   [Full Text] [Related]  

  • 20. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.
    Airaksinen MM; Mikkonen E
    Med Biol; 1980 Dec; 58(6):341-4. PubMed ID: 6112290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.